Cohen G, Haag-Weber M, Mai B, Deicher R, Hörl W H
Department of Medicine, University of Vienna, Austria.
J Am Soc Nephrol. 1995 Dec;6(6):1592-9. doi: 10.1681/ASN.V661592.
Circulating plasma factors accumulating in the serum of uremic patients have the potential to inhibit essential functions of polymorphonuclear leukocytes (PMNL). As a consequence, these factors can contribute to the increased risk for bacterial infections generally found in uremic patients. Free immunoglobulin light chains that are present in the serum of healthy adults at low levels appear in the serum of uremic patients at significantly higher levels. Therefore, kappa and lambda light chains in their monomeric and dimeric forms were isolated from hemodialysis and continuous ambulatory peritoneal dialysis patients and their potential to inhibit essential PMNL functions in in vitro assays was tested. It was found that all isolates tested were able to inhibit deoxyglucose uptake, a measure for the state of activation of PMNL, as well as chemotaxis. In contrast, free immunoglobulin light chains had no influence on the phagocytotic functions of PMNL. It was concluded that free immunoglobulin light chains are able to act as uremic toxins by interfering with essential PMNL functions and that their serum levels and fate during the treatment of uremic patients should be taken into consideration.
在尿毒症患者血清中积累的循环血浆因子有可能抑制多形核白细胞(PMNL)的基本功能。因此,这些因子可能导致尿毒症患者普遍存在的细菌感染风险增加。健康成年人血清中低水平存在的游离免疫球蛋白轻链在尿毒症患者血清中的水平显著升高。因此,从血液透析和持续性非卧床腹膜透析患者中分离出单体和二聚体形式的κ和λ轻链,并在体外试验中测试它们抑制PMNL基本功能的潜力。结果发现,所有测试的分离物都能够抑制脱氧葡萄糖摄取(一种衡量PMNL激活状态的指标)以及趋化性。相比之下,游离免疫球蛋白轻链对PMNL的吞噬功能没有影响。得出的结论是,游离免疫球蛋白轻链能够通过干扰PMNL的基本功能而作为尿毒症毒素起作用,并且在治疗尿毒症患者期间应考虑它们的血清水平和转归。